ResearcherUniversity of MiamiActive in the last 2 years
Gretel Terrero
Matched on ORCID iD 0000-0003-1510-2555; OpenAlex author ID A5015018124. Sources: ClinicalTrials.gov.
Their work
- Papers
- 4
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 trial · 2026: 3 papers
Papers 4
- Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18664-0↗
- ASO Visual Abstract: Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18846-w↗
- Cost-Effectiveness of Daraxonrasib vs Chemotherapy in Previously Treated Metastatic Pancreatic Adenocarcinoma Co-author DOI 10.64898/2026.09.16.26363246↗
- Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer-A Systematic Review and Meta… Co-author DOI 10.3390/cancers13174326↗
Trials 1
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Peter J. Hosein · 3 shared papers, 2026 · strength 0.94
- Paper Cost-Effectiveness of Daraxonrasib vs Chemotherapy in Previously Treated Metastatic Pancreatic Adenocarcinoma DOI 10.64898/2026.09.16.26363246↗
- Paper Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer. DOI 10.1245/s10434-025-18664-0↗
- Paper ASO Visual Abstract: Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cance… DOI 10.1245/s10434-025-18846-w↗
- Erin M. Dickey · 2 shared papers, 2026 · strength 0.56
- Caitlin A. Hester · 2 shared papers, 2026 · strength 0.56
- Mary P Martos · 2 shared papers, 2026 · strength 0.56
- Nipun B. Merchant · 2 shared papers, 2026 · strength 0.56
- Jashodeep Datta · 2 shared papers, 2026 · strength 0.56
- Sunwoo Han · 1 shared paper, 2026 · strength 0.39
- Gilberto De Lima Lopes Jr. · 1 shared paper, 2026 · strength 0.39
- Marko Damm · 1 shared paper, 2021 · strength 0.13
- Sebastian Krug · 1 shared paper, 2021 · strength 0.13
- Jonas Rosendahl · 1 shared paper, 2021 · strength 0.13
- Jorg H. Kleeff · 1 shared paper, 2021 · strength 0.13
- Patrick Michl · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.